APP and Alzheimer disease: In AD, the observations that (1) a C-terminal KFERQ motif is present in both Tau and Amyloid Precursor Proteins (APPs), (2) mutations in the Tau protein reduce CMA activity, and (3) the efficacy of CMA declines with age help explain the pathogenesis of disease-associated autophagy alterations [3].